These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18397985)

  • 1. 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
    Miyauchi A; Takamura Y; Ito Y; Miya A; Kobayashi K; Matsuzuka F; Amino N; Toyoda N; Nomura E; Nishikawa M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2239-42. PubMed ID: 18397985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma.
    Takano T; Miyauchi A; Ito Y; Amino N
    Thyroid; 2006 Jun; 16(6):615-8. PubMed ID: 16839265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels.
    Kim BW; Daniels GH; Harrison BJ; Price A; Harney JW; Larsen PR; Weetman AP
    J Clin Endocrinol Metab; 2003 Feb; 88(2):594-8. PubMed ID: 12574186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly Differentiated Thyroid Carcinoma Coexisting with Graves' Disease Involving T3 Thyrotoxicosis due to Increased D1 and D2 Activities.
    Okazaki-Hada M; Maruoka A; Yamamoto M; Ito M; Hirokawa M; Nishikawa M; Akamizu T; Miyauchi A; Toyoda N
    Thyroid; 2021 Oct; 31(10):1592-1596. PubMed ID: 34278816
    [No Abstract]   [Full Text] [Related]  

  • 5. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
    Ito M; Toyoda N; Nomura E; Takamura Y; Amino N; Iwasaka T; Takamatsu J; Miyauchi A; Nishikawa M
    Eur J Endocrinol; 2011 Jan; 164(1):95-100. PubMed ID: 20937676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.
    Hoftijzer HC; Heemstra KA; Visser TJ; le Cessie S; Peeters RP; Corssmit EP; Smit JW
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1527-33. PubMed ID: 21715540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy.
    Ito M; Miyauchi A; Morita S; Kudo T; Nishihara E; Kihara M; Takamura Y; Ito Y; Kobayashi K; Miya A; Kubota S; Amino N
    Eur J Endocrinol; 2012 Sep; 167(3):373-8. PubMed ID: 22711760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases.
    Kasagi K; Takeuchi R; Miyamoto S; Misaki T; Inoue D; Shimazu A; Mori T; Konishi J
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):429-34. PubMed ID: 8187309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
    Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
    Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
    de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival.
    Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH
    Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.
    Legakis I; Manousaki M; Detsi S; Nikita D
    Acta Med Iran; 2013; 51(1):25-34. PubMed ID: 23456581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.
    Olveira G; Almaraz MC; Soriguer F; Garriga MJ; Gonzalez-Romero S; Tinahones F; Ruiz de Adana MS
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):707-11. PubMed ID: 9274701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotoxicosis caused by thyroid cancer.
    Paul SJ; Sisson JC
    Endocrinol Metab Clin North Am; 1990 Sep; 19(3):593-612. PubMed ID: 2261908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iodothyronine deiodinases expression in thyroid neoplasias].
    Meyer EL; Wagner MS; Maia AL
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):690-700. PubMed ID: 17891232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T3 thyrotoxicosis in a patient with a hormonally active, metastasizing follicular thyroid carcinoma].
    Johansen AH; Nielsen BV
    Ugeskr Laeger; 1994 Jan; 156(4):483-4. PubMed ID: 8140667
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thyroid function and thyroid autoimmunity at the late pregnancy: data from 664 pregnant women].
    Guan HX; Li CY; Li YS; Fan CL; Teng Y; Ouyang YH; Cong Q; Teng WP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):529-32. PubMed ID: 17083836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
    Schreck R; Schnieders F; Schmutzler C; Köhrle J
    J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A clinical study on gestational transient thyrotoxicosis].
    Wen BH; Teng WP; Shan ZY; Li YB; Li J; Gao B; Shang T; Zhou JR; Li CY; Zhou WW; Ding B; Ma Y; Wu Y; Liu Q; Liu W; Yu XH; Chen YY; Wang WW; Fan CL; Wang H; Guo R
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1003-7. PubMed ID: 19134305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.